London, June 19, 2026, 12:04 BST
- Experian rose 0.76% to 2,528 pence by 11:42 BST, after trading between 2,483p and 2,550p.
- The stock closed Thursday at 2,509p, with 8.67 million shares changing hands.
- Experian is targeting fiscal 2027 organic revenue growth of 6%–8%, while its new $1 billion share-buyback programme runs through June 2027.
Experian shares edged higher on Friday as investors weighed fresh purchases under the credit-data group’s buyback against the cost of a new $1 billion bond. The stock was quoted at 2,527p to sell and 2,528p to buy, up about 0.7%.
The gain offered only a modest repair after Thursday’s 1.9% decline. Experian ended that session at £25.09 on volume of about 8 million shares, well above its recent daily average, and remained nearly 39% below last July’s 52-week high.
That matters because the broader London market was almost flat on Friday. The FTSE 100 slipped 0.05% in early trade as cancelled U.S.-Iran talks restrained risk appetite, although oil producers and healthcare stocks provided support. Experian’s advance therefore represented some stock-specific recovery rather than a broad market lift.
A disclosure published Friday showed Experian repurchased 468,800 shares on June 18 at a weighted average price of 2,530.6026p. J.P. Morgan Securities handled the purchases, and the shares will be cancelled, reducing the number in circulation and mechanically supporting earnings per share. The purchase price sits close to Friday’s market quote; it is a useful support marker, but not a new revenue catalyst.
Experian also priced $1 billion of 5.35% bonds due in August 2036 through its U.S. finance subsidiary. The company said the proceeds would fund general corporate purposes and repay some existing debt. Extending maturities lowers near-term refinancing pressure, but the 5.35% coupon — the annual interest rate paid to bondholders — shows that long-term capital is not cheap. The issue is due to close on June 24.
The larger argument around the shares remains growth. Experian expects fiscal 2027 organic revenue growth of 6%–8%, an underlying measure stated at constant currency, against a company-compiled analyst range of 6.3%–9.8%. Chief Executive Brian Cassin said last month that he saw “no material improvements” but also “no material deterioration” in the outlook. JPMorgan analyst Jane Sparrow said management would need to keep addressing “AI-related nervousness” among investors. Reuters
Experian competes with Equifax and TransUnion as one of the three nationwide U.S. credit-reporting agencies. All three supply information used by lenders and other businesses, leaving demand sensitive to credit activity and shifts in lenders’ appetite for risk.
But the risks remain. Repurchases can improve per-share measures without fixing slower customer spending, while the bond adds interest expense. A weaker lending cycle or continued concern that artificial intelligence could reduce the value of some data-analysis services may keep the valuation under pressure. The sharp May decline after Experian’s outlook missed expectations showed how little room investors are allowing for softer growth.
The next technical event is June 25, when the shares trade ex-dividend and new buyers cease to qualify for the forthcoming distribution. The more important test comes on July 16, when Experian is scheduled to publish its first-quarter trading update and show whether its 6%–8% growth range remains on course.
